Please login to the form below

Not currently logged in
Email:
Password:

vedolizumab

This page shows the latest vedolizumab news and features for those working in and with pharma, biotech and healthcare.

Takeda’s Entyvio recommended by NICE for bowel disease

Takeda’s Entyvio recommended by NICE for bowel disease

NICE has recommended Entyvio (vedolizumab) to treat moderate to severe ulcerative colitis in final draft guidance. ... Vedolizumab works in a different way to other treatment options [by] targeting the immune system in the gut rather than the whole body

Latest news

More from news
Approximately 8 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Interview: Trevor Smith, Takeda Interview: Trevor Smith, Takeda

    There's prostate cancer drug orteronel (TAK-700) and vedolizumab for Crohn's disease and ulcerative colitis, and then the atypical antipsychotic lurasidone. ... From among its product pipeline Smith picks prostate cancer drug orteronel (TAK-700),

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hall & Partners

We are a specialist brand and communications research consultancy offering you fresh ideas at every stage of the brand planning...

Latest intelligence

Competition from within
Published in eyeforpharma July 29 by Rachel Howard...
Infographic: RA Perceptions
HCPs predict the future of the biologics market...
From chaos to calm: how to make sense of social media
What do you know about chaos theory?...

Infographics